106 related articles for article (PubMed ID: 24334802)
21. Classification of breast tissue expander infections: Back to the basics.
Kraenzlin FS; Saunders H; Aliu O; Cooney D; Rosson GD; Sacks JM; Broderick K; Manahan MA
J Surg Oncol; 2019 Aug; 120(2):142-147. PubMed ID: 31102461
[TBL] [Abstract][Full Text] [Related]
22. Activity of antimicrobial-impregnated silicone tissue expanders.
Darouiche RO; Netscher DT; Mansouri MD; Meade R
Ann Plast Surg; 2002 Dec; 49(6):567-71. PubMed ID: 12461436
[TBL] [Abstract][Full Text] [Related]
23. Microbiologic characteristics and in vitro susceptibility to antimicrobials in a large population of patients with cardiovascular implantable electronic device infection.
Jan E; Camou F; Texier-Maugein J; Whinnett Z; Caubet O; Ploux S; Pellegrin JL; Ritter P; Metayer PL; Roudaut R; Haissaguerre M; Bordachar P
J Cardiovasc Electrophysiol; 2012 Apr; 23(4):375-81. PubMed ID: 22082221
[TBL] [Abstract][Full Text] [Related]
24. Microbiological evaluation of tissue expanders in patients who had first stage breast reconstruction.
Marangi GF; Langella M; Gherardi G; Petitti T; Gigliofiorito P; Dicuonzo G; Persichetti P
J Plast Surg Hand Surg; 2010 Nov; 44(4-5):199-203. PubMed ID: 21446816
[TBL] [Abstract][Full Text] [Related]
25. Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics.
Chua K; Howden BP
Curr Opin Infect Dis; 2009 Dec; 22(6):525-34. PubMed ID: 19738465
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Current Perioperative Antimicrobial Regimens for the Prevention of Surgical Site Infections in Breast Implant-based Reconstructive Surgeries.
Viola GM; Rolston KV; Butler C; Selber J; Reece G; Clemens M; Villa M; Raad II; Baumann D
Plast Reconstr Surg Glob Open; 2019 Jul; 7(7):e2342. PubMed ID: 31942364
[TBL] [Abstract][Full Text] [Related]
27. Improving Antimicrobial Regimens for the Treatment of Breast Tissue Expander-Related Infections.
Viola GM; Baumann DP; Mohan K; Selber J; Garvey P; Reece G; Raad II; Rolston KV; Crosby MA
Plast Reconstr Surg Glob Open; 2016 May; 4(5):e704. PubMed ID: 27579229
[TBL] [Abstract][Full Text] [Related]
28. Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention.
Moran E; Masters S; Berendt AR; McLardy-Smith P; Byren I; Atkins BL
J Infect; 2007 Jul; 55(1):1-7. PubMed ID: 17343916
[TBL] [Abstract][Full Text] [Related]
29. The influence of AlloDerm on expander dynamics and complications in the setting of immediate tissue expander/implant reconstruction: a matched-cohort study.
Preminger BA; McCarthy CM; Hu QY; Mehrara BJ; Disa JJ
Ann Plast Surg; 2008 May; 60(5):510-3. PubMed ID: 18434824
[TBL] [Abstract][Full Text] [Related]
30. Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp.
Ng J; Gosbell IB
J Antimicrob Chemother; 2005 Jun; 55(6):1008-12. PubMed ID: 15845784
[TBL] [Abstract][Full Text] [Related]
31. Toyota production system quality improvement initiative improves perioperative antibiotic therapy.
Burkitt KH; Mor MK; Jain R; Kruszewski MS; McCray EE; Moreland ME; Muder RR; Obrosky DS; Sevick MA; Wilson MA; Fine MJ
Am J Manag Care; 2009 Sep; 15(9):633-42. PubMed ID: 19747028
[TBL] [Abstract][Full Text] [Related]
32. Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection.
Turgut H; Sacar S; Kaleli I; Sacar M; Goksin I; Toprak S; Asan A; Cevahir N; Tekin K; Baltalarli A
BMC Infect Dis; 2005 Oct; 5():91. PubMed ID: 16242027
[TBL] [Abstract][Full Text] [Related]
33. Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis.
Al-Nammari SS; Bobak P; Venkatesh R
Arch Orthop Trauma Surg; 2007 Sep; 127(7):537-42. PubMed ID: 17260151
[TBL] [Abstract][Full Text] [Related]
34. Post-cesarean delivery infectious morbidity: Focus on preoperative antibiotics and methicillin-resistant Staphylococcus aureus.
Thurman AR; Anca Y; White CA; Soper DE
Am J Infect Control; 2010 Oct; 38(8):612-6. PubMed ID: 20627452
[TBL] [Abstract][Full Text] [Related]
35. Is there any rationale for treatment of Staphylococcus aureus infections with antimicrobials that are determined to be ineffective in vitro?
Uekötter A; Peters G; Becker K
Clin Microbiol Infect; 2011 Aug; 17(8):1142-7. PubMed ID: 21672081
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors for infections of methicillin-resistant Staphylococci in diabetic foot patients].
Ding Q; Li DQ; Wang PH; Chu YJ; Meng SY; Sun Q
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):228-31. PubMed ID: 22490791
[TBL] [Abstract][Full Text] [Related]
37. Recovery of the susceptibility of isolated bacterium achieved by giving long-established antibiotics as prophylaxis against postoperative infections.
Kusachi S; Sumiyama Y; Arima Y; Yoshida Y; Nakamura Y; Tanaka H; Nagao J; Saida Y; Watanabe M; Sato J
Surg Today; 2004; 34(9):725-31. PubMed ID: 15338342
[TBL] [Abstract][Full Text] [Related]
38. Tissue expander with acellular dermal matrix for breast reconstruction infected by an unusual pathogen: Candida parapsilosis.
Fox PM; Lee GK
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):e286-9. PubMed ID: 22633394
[TBL] [Abstract][Full Text] [Related]
39. Considerations in the choice and administration of agents for empiric antimicrobial therapy.
Baughman RP
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-71-82. PubMed ID: 23577498
[TBL] [Abstract][Full Text] [Related]
40. Long-term reconstructive outcomes after expander-implant breast reconstruction with serious infectious or wound-healing complications.
Peled AW; Stover AC; Foster RD; McGrath MH; Hwang ES
Ann Plast Surg; 2012 Apr; 68(4):369-73. PubMed ID: 22421481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
